NDC 50090-0495-01 - GLYBURIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0495
- Requested NDC
- 50090-0495-01
- Package NDCs from labels
- 50090-0495-8, 50090-0495-0, 50090-0495-1, 50090-0495-9, 50090-0495-2, 50090-0495-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-02-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYBURIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-02-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-0495-0 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-1 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-2 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-8 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-9 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-0 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-1 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-2 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-8 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-9 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0495-0 | GLYBURIDE | 30 in 1 BOTTLE | TABLET | 30 | 11 | |
| 50090-0495-1 | GLYBURIDE | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 50090-0495-2 | GLYBURIDE | 60 in 1 BOTTLE | TABLET | 60 | 11 | |
| 50090-0495-8 | GLYBURIDE | 200 in 1 BOTTLE | TABLET | 200 | 11 | |
| 50090-0495-9 | GLYBURIDE | 90 in 1 BOTTLE | TABLET | 90 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0495 | GLYBURIDE TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 5 package rows | 20230208_3c91a408-973b-4572-832f-515f61d5be1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0495-0 | EA - Each | 50090-0495 | b9e244de-8e38-44d8-86d1-57407ce219e9 | 1 | 2018-09-05 |
| 50090-0495-1 | EA - Each | 50090-0495 | e0d9b6a1-309d-4f09-952f-954336cb1acd | 1 | 2021-08-05 |
| 50090-0495-2 | EA - Each | 50090-0495 | 92d9a2e6-fc66-4a28-a0db-6623a05bab2f | 1 | 2018-09-05 |
| 50090-0495-8 | EA - Each | 50090-0495 | f32350d6-586a-4393-987e-5c30e9c7ef91 | 1 | 2018-09-05 |
| 50090-0495-9 | EA - Each | 50090-0495 | d0272aed-6044-4f1d-ae7f-b8f68b3b32e4 | 1 | 2021-08-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 486fec17-ff83-3bab-e063-6394a90a5ef0 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Northwind Health Company, LLC | adb751e0-19f6-3f41-e053-2a95a90a2df8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | Northwind Health Company, LLC | d9cb9251-7b31-72a0-e053-2a95a90a4315 | 2026-01-01 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | Northwind Health Company, LLC | db47a517-f8bb-136f-e053-2a95a90ad8c5 | 2026-01-01 | Adverse reactions | ANDA090937 310534 SX6K58TVWC |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | A-S Medication Solutions | faa19e1b-2782-4bf1-a93f-84755f7aa53f | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | Chartwell RX, LLC | 7e661288-2d24-4403-86a1-754afa1d04ff | 2025-12-09 | Adverse reactions | ANDA090937 310537 197737 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Coupler LLC | 4573af7f-3c71-e323-e063-6394a90aa9eb | 2025-12-08 | Warnings, Adverse reactions | 310534 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 33418bba-c5ea-4c0f-9d28-31dc2724c6c3 | 2025-10-31 | Adverse reactions | ANDA090937 23155-058 310537 197737 310534 98ed9f46-1633-4f82-bd51-ff87b0157871 33418bba-c5ea-4c0f-9d28-31dc2724c6c3 SX6K58TVWC |
| Glyburide | GLYBURIDE | Bryant Ranch Prepack | db074991-1267-454a-8b1d-b6f52e2132cc | 2025-10-03 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | 6f65131c-90df-45ab-95fb-c36f411c6fbe | 2025-07-01 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | d2b109e4-b743-4c5b-98fa-8e1ff4491dd0 | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals,Inc. | 7ee41cd3-461f-3408-e053-2991aa0a863d | 2025-02-06 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | Bryant Ranch Prepack | 05341afe-5b7a-462a-a196-689cb09f83fc | 2025-01-28 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | A-S Medication Solutions | 676c0e45-0aa2-4060-ad18-67abb9873a50 | 2024-10-28 | Warnings, Adverse reactions | 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals, Inc. | 25516c2a-f1b5-9ee4-e063-6394a90ab46b | 2024-10-25 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals, Inc. | 21786ac0-da3c-16cb-e063-6394a90a4596 | 2024-09-06 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals, Inc. | 3e354b4d-70e4-5089-e054-00144ff88e88 | 2024-08-13 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | NuCare Pharmaceuticals,Inc. | a12342fb-123c-2951-e053-2a95a90ac596 | 2024-06-20 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | NuCare Pharmaceuticals,Inc. | a1233548-bbb8-34aa-e053-2a95a90aea53 | 2024-06-20 | Adverse reactions | ANDA090937 310534 SX6K58TVWC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.